ID: ALA3427366

Max Phase: Preclinical

Molecular Formula: C17H16F2N2O2

Molecular Weight: 318.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Oc1ccc(F)c(F)c1)N1CCN(c2ccccc2)CC1

Standard InChI:  InChI=1S/C17H16F2N2O2/c18-15-7-6-14(12-16(15)19)23-17(22)21-10-8-20(9-11-21)13-4-2-1-3-5-13/h1-7,12H,8-11H2

Standard InChI Key:  KAZVABOQPWEQTM-UHFFFAOYSA-N

Associated Targets(non-human)

Patatin-like phospholipase domain-containing protein 2 302 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.32Molecular Weight (Monoisotopic): 318.1180AlogP: 3.29#Rotatable Bonds: 2
Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.41CX LogP: 3.72CX LogD: 3.72
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.85Np Likeness Score: -1.76

References

1. Mayer N, Schweiger M, Melcher MC, Fledelius C, Zechner R, Zimmermann R, Breinbauer R..  (2015)  Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL).,  23  (12): [PMID:25778769] [10.1016/j.bmc.2015.02.051]

Source